Skip to main content
SpringerLink
Log in

Klassifikationen, Erkrankungsverläufe und Symptomatologie

  • Conference paper
Vorhofflimmern Vorhofflattern

  • 1013 Accesses

Auszug

Die Uneinheitlichkeit der Nomenklatur und der Klassifikation des Vorhof-flimmerns war national und international so groß, dass sich im Juni 2000 eine Gruppe von Kardiologen und Elektrophysiologen zu einer Konferenz zu diesem Thema zusammenfand. Deren Ergebnisse sind zum einen in die Richtlinien internationaler Gesellschaften eingeflossen [11], zum anderen wurden sie separat im Jahre 2003 publiziert [29]. Im klinischen Alltag hat sich die Verwendung dieser vereinheitlichten Nomenklatur bisher nicht ausreichend durchgesetzt. Bevor die Ergebnisse dieser Konferenz vorgestellt werden, sollen kurz die grundsätzlichen Erwägungen und Möglichkeiten bei der Nomenklatur und Klassifikation des Vorhofflimmerns diskutiert werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. The AFFIRM investigators (2005) Quality of life in atrial fibrillation: The atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Am Heart J 149:112–120

    Article  Google Scholar 

  2. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ Jr, Cohn LH, Burstin HR (1996) Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94:390–397

    PubMed  CAS  Google Scholar 

  3. Bhandari AK, Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Cullen MT Jr, Hawkinson RW, Pritchett EL (1992) Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Am Heart J 124:381–386

    Article  PubMed  CAS  Google Scholar 

  4. Brand FN, Abbott RD, Kannel WB, Wolf PA (1985) Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. J Am Med Ass 254:3449–3453

    Article  CAS  Google Scholar 

  5. Callans DJ (2004) Asymptomatic atrial fibrillation in symptomatic patients. J Cardiovasc Electrophysiol 15:925–926

    Article  PubMed  Google Scholar 

  6. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS (1988) Prevalence and significance of atrial fibrillation in coronary artery disease (CASS registry). Am J Cardiol 61:714–717

    Article  PubMed  CAS  Google Scholar 

  7. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U; STAF Investigators (2003) Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 41:1690–1696

    Article  PubMed  Google Scholar 

  8. Darbar D, Roden DM (2005) Symptomatic burden as an endpoint to evaluate interventions in patients with atrial fibrillation. Heart Rhythm 2:544–549

    Article  PubMed  Google Scholar 

  9. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, Camm J, Akhtar M, Luderitz B (2000) The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 36:1303–1309

    Article  PubMed  CAS  Google Scholar 

  10. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, and the AFFIRM Investigators (2005) Asymptomatic atrial fibrillation: demographic features and prognostic information from the AFFIRM study. Am Heart J 149:657–663

    Article  PubMed  Google Scholar 

  11. Fuster V, Rydén LE, Asinger RW, et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 22:1852–1923

    Article  PubMed  CAS  Google Scholar 

  12. Gallagher MM, Camm AJ (1997) Classification of atrial fibrillation. Pacing Clin Electrophysiol 20:1603–1605

    Article  PubMed  CAS  Google Scholar 

  13. Go AS, Hylek EM, Phillips KA, Chang YC, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the antigoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 285:2370–2375

    Article  PubMed  CAS  Google Scholar 

  14. Grönefeld GC, Lilienthal J, Kuck KH, Hohnloser SH, for the PIAF Investigators (2003) Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. Eur Heart J 24:1430–1436

    Article  PubMed  Google Scholar 

  15. Hagen VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JGP, Kingma JH, Crijns HJGM, Van Gelder IC, for the RACE Study Group (2004) Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results of the RACE study. J Am Coll Cardiol 43:241–247

    Article  Google Scholar 

  16. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666

    Article  PubMed  CAS  Google Scholar 

  17. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Scavee C, Bordachar P, Clementy J, Haissaguerre M (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373–2383

    Article  PubMed  CAS  Google Scholar 

  18. Israel CW, Gronefeld G, Ehrlich Jr, Li YG, Hohnloser SH (2004) Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 43:47–52

    Article  PubMed  Google Scholar 

  19. Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of atrial fibrillation: the Framingham study. N Engl J Med 306:1018–1022

    PubMed  CAS  Google Scholar 

  20. Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, Lamprecht K, Barthel P, Luciani E, Schömig A, Schmitt C (2005) Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation. A randomized comparison between 2 current ablation strategies. Circulation 111:2875–2880

    Article  PubMed  Google Scholar 

  21. Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, Boone J, Sheldon R, Dorian P, Newman D (2005) Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 149:489–496

    Article  PubMed  Google Scholar 

  22. Komatsu T, Nakamura S, Suzuki O, Horiuchi D, Yomogida K, Okumura K (2004) Long-term prognosis of patients with proxysmal fibrillation depends on their response to antiarrhythmic therapy. Circ J 68:729–733

    Article  PubMed  Google Scholar 

  23. Konings KT, Kirchhof CJ, Smeets Jr, Wellens HJ, Penn OC, Allessie MA (1994) High-density mapping of electrically induced atrial fibrillation in humans. Circulation 89:1665–1680

    PubMed  CAS  Google Scholar 

  24. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL (1987) The natural history of lone atrial fibrillation: a population based study over three decades N Engl J Med 317:669–674

    PubMed  CAS  Google Scholar 

  25. Kopecky SL, Gersh BJ, McGoon MD, Chu CP, Ilstrup DM, Chesebro JH, Whisnant JP (1999) Lone atrial fibrillation in elderly persons. A marker for cardiovascular risk. Arch Intern Med 159:1118–1122

    Article  PubMed  CAS  Google Scholar 

  26. Levy S, Novella P, Ricard P, Paganelli F (1995) Paroxysmal atrial fibrillation: A need for classification. J Cardiovasc Electrophysio 6:69–74

    Article  CAS  Google Scholar 

  27. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A (1999) Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation 99:3028–3035

    PubMed  CAS  Google Scholar 

  28. Levy S (2000) Classification system of atrial fibrillation. Current opinion in Cardiology 15:54–57

    Article  PubMed  CAS  Google Scholar 

  29. Levy S, Camm AJ, Saksena S, Aliot E, Breithardt G, Crijns H, Davies W, Kay N, Prystowsky E, Sutton R, Waldo A, Wyse DG; Working Group on Arrhythmias, Working Group on Cardiac Pacing of the European Society of Cardiology, Northmerican Society of Pacing and Electrophysiology (2003) International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Europace 5:119–112

    Article  PubMed  CAS  Google Scholar 

  30. Lloyd-Jones DM, Wang TJ, Leip EP, Larson M, Levy D, Vasan R, DAgostino RB, Massaro JM, Beiser A, Wolf P, Benjamin E (2004) Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation 110: 1042–1046

    Article  PubMed  Google Scholar 

  31. Lüderitz B, Jung W (2000) Quality of life in patients with atrial fibrillation. Arch Intern Med 160:1749–1757

    Article  PubMed  Google Scholar 

  32. Maisel WH, Stevenson LW (2003) Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91: 2D–8D

    Article  PubMed  Google Scholar 

  33. Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature 415: 219–226

    Article  PubMed  CAS  Google Scholar 

  34. Newman D (2005) Atrial fibrillation and quality of life: clarity or evidence-based confusion? Am Heart J 149:4–6

    Article  PubMed  Google Scholar 

  35. Pacifico A, Henry PD (2004) Ablation for atrial fibrillation: are cures really achieved? J Am Coll Cardiol 43(11):1940–1942

    Article  PubMed  Google Scholar 

  36. Page RL, Tilsch TW, Connolly SJ, Schnell DJ, Marcello SR, Wilkinson WE, Pritchett EL; Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators (2003) Asymptomatic or „silent“ atrial fibrillation: frequency in untreated patients and patients receiving azimilide. Circulation 107:1141–1145

    Article  PubMed  Google Scholar 

  37. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, Gugliotta F, Pappone A, Santinelli V, Tortoriello V, Sala S, Zangrillo A, Crescenzi G, Benussi S, Alfieri O (2003) Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 42:185–197

    Article  PubMed  Google Scholar 

  38. Parkash R, Green MS, Kerr CR, Connolly SJ, Klein GJ, Sheldon R, Talajic M, Dorian P, Humphries KH; Canadian Registry of Atrial Fibrillation (2004) The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 148:649–654

    Article  PubMed  Google Scholar 

  39. Patten M, Maas R, Bauer P, Luderitz B, Sonntag F, Dluzniewski M, Hatala R, Opolski G, Muller HW, Meinertz T (2004) SOPAT Investigators Suppression of paroxysmal atrial tachyarrhythmias-results of the SOPAT trial. Eur Heart J 25:1395–1404

    Article  PubMed  Google Scholar 

  40. Pritchett ELC (1998) The case for just plain „atrial fibrillation“. Pacing Clin Electrophysiol 21:637–640

    Article  PubMed  CAS  Google Scholar 

  41. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455–2461

    PubMed  CAS  Google Scholar 

  42. Pürfellner H, Martinek M, Aichinger J, Nesser HJ, Kempen K, Janssen J (2004) Quality of life restored to normal in patients with atrial fibrillation after pulmonary vein ostial isolation. Am Heart J 148:318–325

    Article  Google Scholar 

  43. Savelieva I, Camm AJ (2000) Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Intervent Cardiac Electrophysiol 4:369–382

    Article  CAS  Google Scholar 

  44. Scardi S, Mazzone C, Pandullo C, Goldstein D, Poletti A, Humar F (1999) Lone atrial fibrillation: Prognostic differences between paroxysmal and chronic forms after 10 years of follow-up Am Heart J 137:686–691

    Article  PubMed  CAS  Google Scholar 

  45. Smeets JL (2005) Paroxysmal atrial fibrillation: why patients experience different symptoms from the same arrhythmia? Neth J Med 63:154–155

    PubMed  CAS  Google Scholar 

  46. Stevenson WG, Stevenson LW (2004) Atrial fibrillation and heart failure — five more years. N Engl J Med 351:2437–2440

    Article  PubMed  CAS  Google Scholar 

  47. Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD (2005) Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm 2:125–131

    Article  PubMed  Google Scholar 

  48. Tse HF, Lau CP, Yu CM, Lee KLF, Michaud GF, Knight BP, Morady F, Strick-berger SA (1999) Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation. J Cardiovasc Electrophysiol 10:1200–1209

    Article  PubMed  CAS  Google Scholar 

  49. Van den Berg MP, Ranchor AV, van Sonderen FL, van Gelder IC, van Veldhui-sen DJ (2005) Paroxysmal atrial fibrillation, quality of life and neuroticism. Neth J Med 63:170–174

    PubMed  Google Scholar 

  50. Van Gelder IC, Crijns HJGM, Van Gilst WH, Hamer HPM, Lie KI (1991) Decrease of right and left atrial sizes after direct current electrical cardioversion of chronic atrial fibrillation. Am J Cardiol 67:93–95

    Article  PubMed  Google Scholar 

  51. Van Gelder IC, Crijns HJ, Tieleman RG, Brugemann J, De Kam PJ, Gosselink AT, Verheugt FW, Lie KI (1996) Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 156:2585–2592

    Article  PubMed  Google Scholar 

  52. Wijffels MCEF (1999) The natural history of atrial fibrillation: What is the role of atrial remodeling and can we learn from the atrial defibrillator? J Cardiovasc Electrophysiol 10:1210–1213

    Article  PubMed  CAS  Google Scholar 

  53. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A (2003) Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 107:2926–2931

    Article  PubMed  Google Scholar 

  54. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB (2005) Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 45:712–719

    Article  PubMed  CAS  Google Scholar 

  55. Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlof B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB (2005) Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 45:705–711

    Article  PubMed  Google Scholar 

  56. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM (1983) Duration of atrial fibrillation and imminence of stroke: the Framing-ham study. Stroke 14:664–667

    PubMed  CAS  Google Scholar 

  57. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833

    PubMed  CAS  Google Scholar 

  58. Wyse DG, Gersh BJ (2004) Atrial fibrillation: A perspective: Thinking inside and outside the box. Circulation 109:3089–3095

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik Kardiologie Länssjukhuset i Kalmar, Lasarettsvägen, 39185, Kalmar, Schweden

    PD Dr. med. J. Carlsson

  2. Medizinische Klinik II, Klinikum Kassel, Möncheberg Straße 41-43, 34125, Kassel

    Prof. Dr. med. J. Neuzner

  3. Medizinische Klinik und Poliklinik I, Universitätsklinikum Gießen, Klinikstraße 36, 35392, Gießen

    Dr. med. A. Erdogan

Authors
  1. PD Dr. med. J. Carlsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. J. Neuzner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. med. A. Erdogan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik II, Klinikum Kassel, Möncheberg Straße 41-43, 34125, Kassel

    Jörg Neuzner

  2. Kerkhoff-Klinik Abt. für Kardiologie, Benekestraße 2-8, 61231, Bad Nauheim

    Heinz F. Pitschner

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Steinkopff Verlag Darmstadt

About this paper

Cite this paper

Carlsson, J., Neuzner, J., Erdogan, A. (2007). Klassifikationen, Erkrankungsverläufe und Symptomatologie. In: Neuzner, J., Pitschner, H.F. (eds) Vorhofflimmern Vorhofflattern. Steinkopff. https://doi.org/10.1007/978-3-7985-1748-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-7985-1748-6_3

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1506-2

  • Online ISBN: 978-3-7985-1748-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation